Expression and biological significance of c-FLIP in human hepatocellular carcinomas

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Du, Xilin ^a   Bao, Guoqiang ^a   He, Xianli ^a   Zhao, Huadong ^a   Yu, Fang ^b   Qiao, Qing ^a   Lu, Jianguo ^a   Ma, Qingjiu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLICE INHIBITORY PROTEIN; SMALL INTERFERING RNA; CFLAR PROTEIN, HUMAN; MESSENGER RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PLASMID;

ADULT; AGED; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; DOXORUBICIN; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLASMIDS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 62149099613     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-24     Document Type: Article

References (27)

1. Death and anti-death: tumour resistance to apoptosis. FH Igney PH Krammer, Nat Rev Cancer 2002 2 277 88 10.1038/nrc776 12001989
2. Differential sensitivity of endothelial cells of various species to apoptosis induced by gene transfer of Fas ligand: role of FLIP levels. D Bouchet L Tesson S Ménoret B Charreau P Mathieu H Yagita G Duisit I Anegon, Mol Med 2002 8 612 23 12477972
3. Impairment of the ubiquitin-proteasome system by cellular FLIP. T Ishioka R Katayama R Kikuchi M Nishimoto S Takada R Takada S Matsuzawa JC Reed T Tsuruo M Naito, Genes Cells 2007 12 735 44 17573774
4. Cellular FLICE-inhibitory protein regulates chemotherapy-induced apoptosis in breast cancer cells. KM Rogers M Thomas L Galligan TR Wilson WL Allen H Sakai PG Johnston DB Longley, Mol Cancer Ther 2007 6 1544 51 10.1158/1535-7163.MCT-06-0673 17513603
5. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. D Mezzanzanica E Balladore F Turatti E Luison P Alberti M Bagnoli M Figini A Mazzoni F Raspagliesi M Oggionni S Pilotti S Canevari, Clin Cancer Res 2004 10 5202 14 10.1158/1078-0432.CCR-03-0537 15297424
6. Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis. ML Hyer S Sudarshan Y Kim JC Reed JY Dong DA Schwartz JS Norris, Cancer Biol Ther 2002 1 401 6 12432255
7. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. A Krueger S Baumann PH Krammer S Kirchhoff, Mol Cell Biol 2001 21 8247 54 11713262 10.1128/MCB.21.24.8247-8254.2001
8. Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells. T Kataoka M Ito RC Budd J Tschopp K Nagai, Exp Cell Res 2002 273 256 64 10.1006/excr.2001.5438 11822881
9. Inhibition of death receptor signals by cellular FLIP. M Irmler M Thome M Hahne P Schneider K Hofmann V Steiner JL Bodmer M Schröter K Burns C Mattmann D Rimoldi LE French J Tschopp, Nature 1997 388 190 5 10.1038/40657 9217161
10. c-FLIP: A Key Regulator of Colorectal Cancer Cell Death. TR Wilson KM McLaughlin M McEwan H Sakai KM Rogers KM Redmond PG Johnston DB Longley, Cancer Res 2007 67 5754 62 10.1158/0008-5472.CAN-06-3585 17575142
11. Targeting the FLICE Inhibitory Protein (FLIP) in cancer therapy. H Wajant, Mol Interv 2003 3 124 7 10.1124/mi.3.3.124 14993418
12. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications. P Korkolopoulou AA Saetta G Levidou F Gigelou A Lazaris I Thymara M Scliri K Bousboukea NV Michalopoulos N Apostolikas A Konstantinidou M Tzivras E Patsouris, Histopathology 2007 51 150 6 10.1111/j.1365-2559.2007.02723.x 17559541
13. A system for stable expression of short interfering RNAs in mammalian cells. TR Brummelkamp R Bernards R Agami, Science 2002 296 550 3 10.1126/science.1068999 11910072
14. Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells. M Flahaut A Mühlethaler-Mottet K Auderset KB Bourloud R Meier MB Popovic JM Joseph N Gross, Apoptosis 2006 11 255 63 10.1007/s10495-006-3435-9 16502263
15. Primary liver neoplasms: evaluation of proliferative index using MoAb Ki-67. WF Grigioni A D'Errico F Bacci M Gaudio A Mazziotti G Gozzetti AM Mancini, J Pathol 1989 158 23 9 10.1002/path.1711580107 2547043
16. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. X Yang R Khosravi-Far HY Chang D Baltimore, Cell 1997 89 1067 76 10.1016/S0092-8674(00)80294-9 9215629
17. Genetic control of programmed cell death (apoptosis): prospects for biological tumor staging? MC Jäckel, HNO 1998 46 614 25 10.1007/s001060050283 9677498
18. Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma. H Okano K Shiraki H Inoue T Kawakita T Yamanaka M Deguchi K Sugimoto T Sakai S Ohmori K Fujikawa K Murata T Nakano, Lab Invest 2003 83 1033 43 10.1097/01.LAB.0000079328.76631.28 12861043
19. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. T Kataoka RC Budd N Holler M Thome F Martinon M Irmler K Burns M Hahne N Kennedy M Kovacsovics J Tschopp, Curr Biol 2000 10 640 8 10.1016/S0960-9822(00)00512-1 10837247
20. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. S Kreuz D Siegmund P Scheurich H Wajant, Mol Cell Biol 2001 21 3964 73 11359904 10.1128/MCB.21.12.3964-3973.2001
21. Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer. SH Lee HS Kim SY Kim YS Lee WS Park SH Kim JY Lee NJ Yoo, APMIS 2003 111 309 14 10.1034/j.1600-0463.2003.1110203.x 12716387
22. Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells. RK Thomas A Kallenborn C Wickenhauser JL Schultze A Draube M Vockerodt D Re V Diehl J Wolf, Am J Pathol 2002 160 1521 8 11943736
23. High level of c-FLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells. G Jönsson S Paulie A Grandien, Anticancer Res 2003 23 1213 8 12820373
24. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. P Korkolopoulou A Goudopoulou G Voutsinas E Thomas-Tsagli P Kapralos E Patsouris AA Saetta, Urology 2004 63 1198 204 10.1016/j.urology.2004.01.007 15183989
25. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis. D Siegmund P Hadwiger K Pfizenmaier HP Vornlocher H Wajant, Mol Med 2002 8 725 32 12520089
26. Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP. L Galligan DB Longley M McEwan TR Wilson K McLaughlin PG Johnston, Mol Cancer Ther 2005 4 2026 36 10.1158/1535-7163.MCT-05- 0262 16373718
27. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death. DB Longley TR Wilson M McEwan WL Allen U McDermott L Galligan PG Johnston, Oncogene 2006 25 838 48 10.1038/sj.onc.1209122 16247474